Return to homepagePandemic Pact

Future Materials for the control of airborne disease transmission with the next generation of face masks

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:0 publications

Grant number: 10075383

Grant search

Key facts

  • Disease

    COVID-19, Influenza caused by Influenza A virus subtype H5, Disease X

  • Start & end year

    2023
    2023

  • Known Financial Commitments (USD)

    $62,167.82

  • Funder

    UK Research and Innovation (UKRI)

  • Principal Investigator

    George Fellowes

  • Research Location

    United Kingdom

  • Lead Research Institution

    PARAVIR LIMITED

  • Research Priority Alignment

    N/A

  • Research Category

    Infection prevention and control

  • Research Subcategory

    Barriers, PPE, environmental, animal and vector control measures

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Paravir has developed an **antiviral**, **disposable material** technology for facemasks and other medical nonwovens. Our technology is **recyclable, safe for humans, animals, marine and plant life.** It is also **incredibly cheap to make** meaning antiviral masks can become a standard intervention for variants of Covid 19 (SARS CoV19) and Bird Flu (H5N1). We are seeking grant funding for the construction of a pilot line machine to evaluate the manufacturability of our antimicrobial application. This innovation adds function to off-the-shelf nonwovens which interfere and denature virus, bacteria, fungi and parasites reducing the user's exposure to infectious diseases. Our technology has recently been granted a UK Patent. Product testing has passed ISO 18184 (Antiviral) and ISO 20743 (Antibacterial) Materials.